Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q2 2023 Earnings

8AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.89

-0.66

-0.42

-0.19

Details

Expected EPS

-0.59

Actual EPS

-0.54

Surprise EPS

0.05

Surprise Percent

+8.47%

Description

Fate Therapeutics (FATE) has reported earnings of -0.54 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.